Ana Custódio

VectorB2B-Drug Developing is a non-profit association established in 2019, providing high-quality drug discovery and development services from bench to bedside. We offer not only standard assays but also high-value project design and innovative R&D solutions. Acting as both a solution provider and enabler, we deliver unique assays not typically found in conventional CROs or CMOs. This is made possible by leveraging knowledge and R&D from leading academic and biotech groups at the forefront of biological drug/target discovery, development, and evaluation. VectorB2B serves as a one-stop shop for companies and academia involved in biological drug discovery and development. Our expertise spans across Discovery, Toxicology, CMC, and CRO services, supporting health product development from design, lead selection, and optimization to production, characterization, formulation, and pre-clinical studies.